ProNAi Therapeutics

Micrograph of small cell lung cancer
Research

Attacking drug-resistant tumors with Sierra's CHK1 blocker

British scientists say Sierra's SRA737 has the potential to treat several tumor types as part of a combination with another protein blocker.
Arlene Weintraub Mar 12, 2020 12:13pm
Microscope

Battered and bruised, ProNAi Therapeutics drops PNT2258 completely

Aug 12, 2016 7:36am